Engflag

Taxofit-C

Quick links to important sections

Taxofit-C

Taxofit-C_EN

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Taxofit-C

What is Taxofit-C?

Taxofit-C is a dietary supplement primarily composed of Vitamin C, also known as ascorbic acid. Vitamin C is a water-soluble nutrient that plays an essential role in various biological processes within the human body. Because the body cannot synthesize Vitamin C on its own, it must be obtained through diet or supplementation.

Composition and Properties

The active ingredient in Taxofit-C is ascorbic acid. This compound is recognized for its antioxidant properties, which help protect cells from oxidative stress. In many formulations, Taxofit-C is designed as a high-dose supplement to support the body's physiological requirements during periods when dietary intake may be insufficient.

Primary Functions

Vitamin C is involved in several critical functions that maintain overall health:

  • Collagen Synthesis: It acts as a necessary cofactor for the production of collagen, a structural protein essential for the maintenance of skin, cartilage, tendons, ligaments, and blood vessels.
  • Immune System Support: It contributes to the normal functioning of the immune system by supporting various cellular functions of both the innate and adaptive immune responses.
  • Iron Absorption: It enhances the absorption of non-heme iron, the type of iron found in plant-based foods, by converting it into a form that is more easily absorbed by the digestive tract.
  • Metabolic Processes: It plays a role in energy-yielding metabolism and the reduction of tiredness and fatigue.

Common Uses

Taxofit-C is typically used as a supplemental source of Vitamin C to prevent or address a deficiency. It is often utilized during seasons where the immune system may face increased challenges or by individuals with specific lifestyle factors that may increase the body’s demand for antioxidants.

Regulatory References

  1. Ascorbic Acid (Vitamin C): MedlinePlus Drug Information

What side effects are possible with Taxofit-C?

Possible Side Effects and Safety Information

The safety profile of Taxofit-C, as documented in official government regulatory sources, defines potential risks based on frequency, system affected, and specific patient populations. This information is designed to inform the understanding of the medicine's risk profile without providing prescriptive advice.

Adverse Reactions

The most frequent adverse reactions involve the Gastrointestinal System. These commonly include stomach discomfort, nausea, and diarrhea. The majority of these events are considered non-serious.

Less common but more significant adverse reactions are classified as Rare (occurring in 1 in 1,000 to 1 in 10,000 patients) or Very Rare (less than 1 in 10,000 patients). Serious adverse reactions documented in regulatory sources primarily involve Immune System Disorders (hypersensitivity and allergic reactions) and Renal and Urinary Disorders, including the risk of nephrolithiasis (kidney stone formation).

Safety Restrictions and Considerations

The risk of certain adverse events, notably gastrointestinal disturbances and kidney stone formation, is officially recognized as dose-dependent, meaning the risk increases with higher doses and prolonged exposure.

Population-Specific Safety: Particular caution is required for individuals with certain pre-existing conditions. These include:

  • A predisposition to kidney stone formation.
  • Renal impairment or pre-existing kidney disease.
  • Disorders of iron overload (such as hemochromatosis).

Safety Limitations: Taxofit-C may interfere with the results of certain laboratory tests, potentially leading to inaccurate readings for analytes like glucose and creatinine. Patients must be aware of this potential interference when undergoing diagnostic procedures.

Overdose and Emergency Response

Overdose with Ascorbic Acid (Vitamin C) preparations, such as Taxofit-C, is defined by the clinical manifestations and the potential for severe, life-threatening outcomes documented in regulatory labeling. Initial high-dose exposure, typically from taking more than one gram per day, may present with common gastrointestinal disturbances, including abdominal cramps, diarrhea, nausea, vomiting, and heartburn. Other systemic effects documented include fatigue, flushing, and sleepiness.

The most critical documented risks are associated with chronic excessive intake, particularly over two grams per day, and involve the renal system. These include the development of oxalate nephropathy, nephrolithiasis (kidney stones), and, in cases of massive overdosage, acute renal failure. Specific populations are at heightened risk; individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency are warned against the potential for severe oxidative hemolysis and disseminated intravascular coagulation (DIC).

Regulatory guidance mandates specific actions in these situations. The patient must seek immediate medical attention at the first sign of any severe adverse drug reaction. Furthermore, a doctor must be consulted if the dosage taken exceeds the recommended amount stated on the label. Management is officially described as symptomatic and supportive, focusing on monitoring renal function in at-risk patients, as no specific antidote is available for this overdose.

Therapeutic Uses of Taxofit-C

Quick Facts

  • Supports the maintenance of normal immune function.
  • Contributes to a reduction in fatigue and tiredness.
  • Assists in the normal formation of collagen for the proper function of skin, bones, and cartilage.
  • Aids the body in the protection of cells from oxidative stress.

What Taxofit-C Treats: Main Uses and Benefits

Taxofit-C is a dietary supplement formulation that contains Vitamin C and, in some forms, Zinc, to provide nutritional support.

This supplement is typically used to assist in meeting the body’s daily requirements for these nutrients, particularly when intake from diet may be inadequate. Adequate intake of Vitamin C (ascorbic acid) supports the body in maintaining the normal function of the immune system and contributes to the maintenance of connective tissue, including for normal wound healing. It also helps to reduce tiredness and fatigue.

In formulations containing Zinc, the mineral contributes to the normal function of the immune system and to the maintenance of normal skin, hair, and nails. Both Vitamin C and Zinc aid the body’s cells in protection against oxidative stress.

Appropriate nutrient intake is a foundational component of overall health management.

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

Taxofit-C is contraindicated in individuals with known hypersensitivity to Ascorbic Acid or any component of the specific formulation. Use of daily doses greater than 1 gram is formally contraindicated for patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency due to the labeled risk of severe hemolysis.

Conditional and Restricted Use

Official labeling specifies conditional eligibility for several population groups. Patients with renal impairment, renal disease, or a history of oxalate kidney stones are considered at increased risk for oxalate nephropathy, particularly with high or prolonged intake. Caution is required for individuals with iron overload conditions, as Ascorbic Acid promotes iron absorption.

Age and State Limitations

The eligibility profile notes restrictions for specific age groups and physiological states. Pediatric patients less than 2 years old and geriatric patients are listed as being at increased risk for oxalate-related complications. For pregnant and lactating women, daily intake greater than 1 gram is not recommended; use is restricted to adherence to the established official Recommended Dietary Allowance or Adequate Intake limits.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Ascorbic Acid (Vitamin C) identifies several interactions, primarily involving altered substance exposure and pharmacodynamic effects.

Interaction scope

Category Official Regulatory Statement
Medicinal product categories with documented interactions Oral Anticoagulants, Aluminum-containing Antacids, Iron Preparations, Metal Chelators, pH-sensitive Drugs.
Specific interacting medicines (if explicitly listed) Warfarin, Deferoxamine, Ferrous Salts, Acetylsalicylic Acid.
Mechanistic basis of interactions (only if stated in label) pH modification; alteration of systemic exposure (e.g., increased absorption).
Timing-based interaction rules (if applicable) Deferoxamine: Ascorbic Acid must not be initiated until after the first month of Deferoxamine treatment.
Population-specific interaction notes (if applicable) Renal Impairment/Failure: Co-administration with aluminum-containing antacids should be avoided due to increased aluminum toxicity risk. Patients with Cardiac Failure must avoid co-administration with Deferoxamine.
Interaction-related restrictions Co-administration is prohibited with Deferoxamine in cardiac failure and should be avoided with aluminum-containing antacids in renal failure.

Interaction classifications (high-level)

Category Official Regulatory Classification
Interaction severity classification (as defined in official documents) Prohibited (with Deferoxamine in cardiac failure); Use with Caution (Warfarin, Aluminum-containing antacids).
Regulatory basis FDA Prescribing Information, EMA SmPC, NIH MedlinePlus.
Interaction-context constraints (as defined in official documents) Interactions often depend on the dose of Ascorbic Acid and patient co-morbidities (Renal Failure, Cardiac Failure).

Resulting interaction structure

The regulatory profile highlights several specific interactions that alter the body’s exposure to other compounds or interfere with their function:

  • Ascorbic Acid is associated with an increased gastrointestinal absorption of Ferrous Salts (iron preparations).
  • Co-administration with aluminum-containing antacids can increase aluminum systemic exposure; this combination is officially restricted in patients with renal failure.
  • High doses of Ascorbic Acid may potentially interfere with the effect of oral anticoagulants, such as Warfarin.
  • Co-administration with Deferoxamine carries a risk of cardiac dysfunction, necessitating specific timing rules and is prohibited in patients with cardiac failure.
  • Ascorbic Acid may acidify the urine, potentially altering the excretion of pH-sensitive drugs.

Connection to the overall interaction profile

The regulatory documents define the product’s interaction structure primarily through its capacity to modify the exposure of co-administered metal compounds, such as increasing the absorption of iron and aluminum. The profile includes cautions regarding pharmacodynamic interference with specific drug classes and mandates constraints based on patient co-morbidities to manage risks related to exposure modification.

Mechanism of Action

Taxofit-C is a formulation centered around Ascorbic Acid (Vitamin C), an essential biochemical factor that functions across multiple mechanistic domains to influence established pathways. Its action is driven by its role as an electron donor and an essential cofactor for numerous biological enzymes.

Enzyme-Mediated Hydroxylation Pathways

This domain covers its role as a specific electron donor, or cofactor, for several alpha-ketoglutarate-dependent dioxygenases. By maintaining the enzyme-bound iron in its catalytically active reduced state ( Fe^2+), the drug supports the hydroxylation of specific substrates. This action facilitates the production of structural proteins, such as collagen, via the hydroxylation of proline and lysine residues.

Regulation of Cellular Redox Status

This mechanistic domain involves the drug's function as a primary, water-soluble antioxidant within the intracellular and extracellular environment. It operates by scavenging reactive oxygen species (ROS) and reducing specific radical species. This engagement with antioxidant mechanisms functions to decrease the concentration of reactive oxygen species, thereby influencing cellular stability against oxidative stressors.

Dosage and Administration Information

Official Administration Guidelines

Taxofit-C is an oral preparation of Ascorbic Acid (Vitamin C) intended primarily for supplementation and prophylaxis. The route of administration for this product is exclusively by mouth, although the active ingredient is also approved for parenteral (IV, IM, SC) use in deficiency states where oral administration is not feasible.

Dosing and Schedule

Element Official Regulatory Instruction
Dosing Schedule Prophylactic/Maintenance dosing is typically 25 mg to 500 mg once daily. Therapeutic dosing for deficiency correction is higher, generally ranging from 250 mg to 1000 mg per day.
Frequency Maintenance doses are usually administered once daily. Higher therapeutic doses must be administered in divided doses throughout the day to maximize absorption.
Duration Prophylactic use is intended for ongoing, long-term supplementation. Therapeutic use is a short, fixed course, typically for a minimum of two weeks or until the clinical condition is resolved.

Administration Specifics

The medicine may be taken with or without food. Administration must align with the specific dosage form:

  • Chewable tablets must be chewed thoroughly before swallowing.
  • Standard or extended-release solid forms must be swallowed whole and must not be crushed, cut, or chewed.

Age-Group Rules: Pediatric patients require specific, lower, age-adjusted daily doses. Adults and older adults generally follow the standard dosing protocols.

Missed Dose: If a dose is missed, take it as soon as it is remembered. If it is close to the time of the next scheduled dose, skip the missed dose and resume the regular schedule. Do not double the dose to catch up.

The instructions for use are structured to ensure that the patient receives the correct amount of the active substance based on the two primary labeled use contexts: daily maintenance versus acute therapeutic correction.

Recent Clinical Evidence

Research evidence / Overview of studies for Taxofit-C

Evidence for use in Chronic Stable Angina Pectoris

Research examined Taxofit-C in individuals with chronic stable angina pectoris, a condition characterized by fluctuating or episodic manifestations of chest discomfort during exertion. These studies monitored outcomes related to physical discomfort, specifically measuring the amount of exercise patients could perform before reporting discomfort or showing certain changes on a heart rhythm test. Findings describe patterns observed in the studies where a measured increase in exercise duration was reported before the onset of discomfort. Some research highlights changes measured during the study period, describing patterns related to measurements of fewer reported anginal episodes compared to control groups. These studies contribute to the evidence base by describing what has been observed so far regarding short-term changes in symptoms.

Evidence for use in Hypertension

The product was evaluated in studies focusing on hypertension, a condition involving periods of heightened symptoms related to systemic or functional imbalance. Data show patterns related to measurements of changes in both the upper (systolic) and lower (diastolic) blood pressure readings compared to starting levels. Longer-term evidence tracked the recorded occurrence of major cardiovascular events, such as strokes or heart failure episodes, in the observed populations.

Evidence for use in Reducing Cardiovascular Risk in Coronary Heart Disease (CHD)

Research examined Taxofit-C in individuals with established Coronary Heart Disease (CHD). The long-term research describes patterns in the recorded occurrence of tracked serious cardiovascular events when compared to patients receiving placebo over the multi-year study period. Studies report how symptoms evolved in the observed populations, and the overall patterns were generally consistent across several large investigations.

What is Still Uncertain About Taxofit-C Research

Certainty remains low regarding certain specific, long-term outcomes for all populations. Follow-up durations were limited for some indications, meaning the full extent of long-term outcomes is not fully established. Data for certain groups remain insufficient, and comparative evidence against certain other approaches is not available. The results apply only to the populations studied, and the available evidence highlights what is known—and what is still uncertain—about this product.

Frequently Asked Questions (FAQ)

Common questions about Taxofit-C (FAQ)

Q: What is Taxofit-C primarily used for?

Taxofit-C is officially approved for the prevention and treatment of Vitamin C deficiency in adults and adolescents over 12 years of age. It is intended for use when adequate intake cannot be achieved through diet alone. According to regulatory documents, the product's primary purpose is to address this specific nutritional shortage.

Q: Can Taxofit-C be used to boost my immune system?

Vitamin C is recognized as a nutrient essential for the normal function of the immune system. However, the official regulatory approval for Taxofit-C is specifically for the treatment and prevention of Vitamin C deficiency. Regulatory sources focus on correcting or preventing a known deficiency and do not list 'boosting the immune system' as an approved indication.

Q: What should I do if I miss a dose of Taxofit-C?

Official product information on Taxofit-C does not provide explicit instructions for managing a missed dose. When explicit guidance is unavailable, the general practice for medicines is to omit the forgotten dose and proceed with the next scheduled dose. Regulatory guidance typically advises against taking a double dose to compensate.

Q: Is Taxofit-C safe to take during pregnancy or while breastfeeding?

Regulatory information indicates that Taxofit-C may be taken during pregnancy and while breastfeeding if a medical need exists to prevent or treat Vitamin C deficiency. Official guidance emphasizes that use under these circumstances requires medical supervision. It is also advised that the recommended daily dosage should not be exceeded.

Q: What is the typical timeframe before Taxofit-C starts working?

Taxofit-C is intended to correct a nutritional deficiency, but official regulatory documents do not specify a fixed timeframe for noticeable effects. The rate of improvement can vary depending on individual factors and the degree of the deficiency. Consultation with a healthcare provider is recommended for guidance on the expected duration of treatment.

Q: Does Taxofit-C require a prescription?

Taxofit-C is classified as a non-prescription (over-the-counter) medicine in its approved formulations. This means the product can be purchased without a doctor's prescription. It is, however, intended for use according to the official indications and dosage instructions provided on the product label.

Q: Can I take Taxofit-C with food?

According to the official product information, Taxofit-C can be taken with or without food, as its absorption is generally not dependent on meal timing. This allows for flexibility in the daily routine. Patients should always follow the preparation and timing instructions detailed in the product information.

How should Taxofit-C be stored and disposed of?

Taxofit-C must be stored and disposed of according to the official regulatory guidelines for its active ingredient, Ascorbic Acid (Vitamin C), to maintain its stability and ensure safety.

Mandatory Storage and Protection

Storage Requirement Action Mandated by Label
Temperature Store at controlled room temperature (15 C–30 C).
Environmental Protection Protect from moisture and light; store away from excess heat.
Container Integrity Keep the medication in the original container and keep it tightly closed.

Handling and Disposal Instructions

  • Child Safety: It is mandatory to keep Taxofit-C out of the sight and reach of children; always lock safety caps if applicable.
  • Prohibited Environments: Do not store the product in high-humidity areas, and keep from freezing.
  • Disposal: Dispose of unused or expired product in accordance with local regulations and laws. Patients should utilize a drug take-back program if available. Unless the label specifically instructs flushing, do not flush medicine down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Taxofit-C found in:

A-Z Index: